Search Result
Technology Innovation News Survey Feed (RSS)
VALIDATION ASSESSMENT OF IN VITRO ARSENIC BIOACCESSIBILITY ASSAY FOR PREDICTING RELATIVE BIOAVAILABILITY OF ARSENIC IN SOILS AND SOIL-LIKE MATERIALS AT SUPERFUND SITES
U.S. EPA, Office of Land and Emergency Management. OLEM 9355.4-29, 25 pp, 20 Apr 2017
This report summarizes the basis for EPA's determination that the in vitro bioaccessibility (IVBA) method for arsenic has satisfied the validation and regulatory acceptance criteria for application of the method in an appropriate regulatory context. The arsenic method estimates site-specific relative bioavailability (RBA) of arsenic in soils quickly and inexpensively relative to in vivo methods and is well suited for regulatory use in arsenic risk assessment. https://semspub.epa.gov/work/HQ/196751.pdf
This report summarizes the basis for EPA's determination that the in vitro bioaccessibility (IVBA) method for arsenic has satisfied the validation and regulatory acceptance criteria for application of the method in an appropriate regulatory context. The arsenic method estimates site-specific relative bioavailability (RBA) of arsenic in soils quickly and inexpensively relative to in vivo methods and is well suited for regulatory use in arsenic risk assessment. https://semspub.epa.gov/work/HQ/196751.pdf
The Technology Innovation News Survey welcomes your comments and
suggestions, as well as information about errors for correction. Please
contact Michael Adam of the U.S. EPA Office of Superfund Remediation
and Technology Innovation at adam.michael@epa.gov or (703) 603-9915
with any comments, suggestions, or corrections.
Mention of non-EPA documents, presentations, or papers does not constitute a U.S. EPA endorsement of their contents, only an acknowledgment that they exist and may be relevant to the Technology Innovation News Survey audience.
